comparemela.com

Latest Breaking News On - Adriaan moelker - Page 2 : comparemela.com

EQS-News: BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives

EQS-News: BRAIN Biotech AG / Key word(s): Bond BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the.

Japan
Canada
Australia
Frankfurt
Brandenburg
Germany
United-states
United-kingdom
Zwingenberg
Hessen
Stephanie-konle
Michael-schneiders

BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further g

EQS-News: BRAIN Biotech AG / Key word(s): BondBRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives 29.02.2024 / 20:40 CET/CESTThe issuer is solely responsible for the content of this announcement.BRAIN Biotech AG successfully placed EUR 5.0 million con.

Australia
Frankfurt
Brandenburg
Germany
Zwingenberg
Hessen
United-kingdom
Canada
United-states
Japan
Michael-schneiders
Adriaan-moelker

3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24

EQS-News: BRAIN Biotech AG / Key word(s): Quarterly / Interim Statement3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 28.02.2024 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.3M FY 23/24:  BRAIN Biotech looks optimistic to.

Zwingenberg
Hessen
Germany
United-kingdom
Frankfurt
Brandenburg
United-states
Michael-schneiders
Stephanie-konle
Martina-schuster
Adriaan-moelker
Biotech-group

3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 -February 28, 2024 at 01:32 am EST

EQS-News: BRAIN Biotech AG / Key word: Quarterly / Interim Statement 3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24.

Germany
United-states
Zwingenberg
Hessen
United-kingdom
Frankfurt
Brandenburg
Stephanie-konle
Martina-schuster
Adriaan-moelker
Michael-schneiders
Linkedin

Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy

EQS-News: BRAIN Biotech AG / Key word(s): Annual Report/Annual ResultsAnnual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy 17.01.2024 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Annual Report 2022/23: BRAIN Biotech AG successfully executes growth str.

United-kingdom
United-states
Zwingenberg
Hessen
Germany
Frankfurt
Brandenburg
Adriaan-moelker
Martina-schuster
Stephanie-konle
Michael-schneiders
Biocatalysts-ltd

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.